Laboratory of Veterinary Public Health, School of Veterinary Medicine and Animal Sciences, Kitasato University, Higashi 23-35-1, Towada Aomori 034-8628,1
Department of Bacterial Infections, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871,2
Faculty of Pharmaceutical Sciences, Okayama University, Tsushima-Naka, Okayama 700-8530,3
Department of Laboratory Medicine, Kurashiki Central Hospital, Kurashiki, Okayama 710-8602, Japan4
Received 30 July 2002/
Returned for modification 10 September 2002/
Accepted 27 September 2002
| 1. | Aepfelbacher, M., R. Zumbihl, K. Ruckdeschel, C. A. Jacobi, C. Barz, and J. Heesemann. 1999. The tranquilizing injection of Yersinia proteins: a pathogen's strategy to resist host defense. Biol. Chem. 380:795-802.[CrossRef][Medline] |
| 2. | Fujihara, S., C. Ward, I. Dransfield, R. T. Hay, I. J. Uings, B. Hayes, S. N. Farrow, C. Haslett, and A. G. Rossi. 2002. Inhibition of nuclear factor-kappaB activation un-masks the ability of TNF-alpha to induce human eosinophil apoptosis. Eur. J. Immunol. 32:457-466.[CrossRef][Medline] |
| 3. | Gobert, A. P., D. J. McGee, M. Akhtar, G. L. Mendz, J. C. Newton, Y. Cheng, H. L. Mobley, and K. T. Wilson. 2001. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc. Natl. Acad. Sci. USA 98:13844-13849.[Abstract/Free Full Text] |
| 4. | Johnson, D. E., F. M. Calia, D. M. Musher, and A. Goree. 1984. Resistance of Vibrio vulnificus to serum bactericidal and opsonizing factors: relation to virulence in suckling mice and humans. J. Infect. Dis. 150:413-418.[Medline] |
| 5. | Kreger, A., L. DeChatelet, and P. Shirley. 1981. Interaction of Vibrio vulnificus with human polymorphonuclear leukocytes: association of virulence with resistance to phagocytosis. J. Infect. Dis. 144:244-248.[Medline] |
| 6. | Lei, B., F. R. DeLeo, N. P. Hoe, M. R. Graham, S. M. Mackie, R. L. Cole, M. Liu, H. R. Hill, D. E. Low, M. J. Federle, J. R. Scott, and J. M. Musser. 2001. Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis. Nat. Med. 7:1298-1305.[CrossRef][Medline] |
| 7. | Linkous, D. A., and J. D. Oliver. 1999. Pathogenesis of Vibrio vulnificus. FEMS Microbiol. Lett. 174:207-214.[CrossRef][Medline] |
| 8. | Mills, S. D., A. Boland, M. P. Sory, P. van der Smissen, C. Kerbourch, B. B. Finlay, and G. R. Cornelis. 1997. Yersinia enterocolitica induces apoptosis in macrophages by a process requiring functional type III secretion and translocation mechanisms and involving YopP, presumably acting as an effector protein. Proc. Natl. Acad. Sci. USA 94:12638-12643.[Abstract/Free Full Text] |
| 9. | Navarre, W. W., and A. Zychlinsky. 2000. Pathogen-induced apoptosis of macrophages: a common end for different pathogenic strategies. Cell Microbiol. 2:265-273.[CrossRef][Medline] |
| 10. | Ruckdeschel, K., S. Harb, A. Roggenkamp, M. Hornef, R. Zumbihl, S. Kohler, J. Heesemann, and B. Rouot. 1998. Yersinia enterocolitica impairs activation of transcription factor NF- B: involvement in the induction of programmed cell death and in the suppression of the macrophage tumor necrosis factor alpha production. J. Exp. Med. 187:1069-1079.[Abstract/Free Full Text] |
| 11. | Simpson, L. M., V. K. White, S. F. Zane, and J. D. Oliver. 1987. Correlation between virulence and colony morphology in Vibrio vulnificus. Infect. Immun. 55:269-272.[Abstract/Free Full Text] |
| 12. | Slam, D., L. Bandholtz, J. Nilsson, H. Wigzell, B. Christensson, B. Agerberth, and G. Gudmundsson. 2001. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 7:180-185.[CrossRef][Medline] |
| 13. | Strom, M. S., and R. N. Paranjpye. 2000. Epidemiology and pathogenesis of Vibrio vulnificus. Microbes Infect. 2:177-188.[CrossRef][Medline] |
| 14. | Sutton, P., N. R. Newcombe, P. Waring, and A. Mullbacher. 1994. In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi. Infect. Immun. 62:1192-1198.[Abstract/Free Full Text] |
| 15. | Tamplin, M. L., S. Specter, G. E. Rodrick, and H. Friedman. 1985. Vibrio vulnificus resists phagocytosis in the absence of serum opsonins. Infect. Immun. 49:715-718.[Abstract/Free Full Text] |
| 16. | van der Velden, A. W. M., S. W. Lindgren, M. J. Worley, and F. Heffron. 2000. Salmonella pathogenicity island 1-independent induction of apoptosis in infected macrophages by Salmonella enterica serotype Typhimurium. Infect. Immun. 68:5702-5709.[Abstract/Free Full Text] |
| 17. | Weinrauch, Y., D. Drujan, S. D. Shapiro, J. Weiss, and A. Zychlinsky. 2002. Neutrophil elastase targets virulence factors of enterobacteria. Nature 417:91-94.[CrossRef][Medline] |
| 18. | Yoshida, S.-I., M. Ogawa, and Y. Mizuguchi. 1985. Relation of capsular materials and colony opacity to virulence of Vibrio vulnificus. Infect. Immun. 47:446-451.[Abstract/Free Full Text] |
| 19. | Zhang, J. H., and M. Xu. 2000. DNA fragmentation in apoptosis. Cell Res. 10:205-211.[CrossRef][Medline] |
| 20. | Zhou, X., A. Zhao, G. Gopping, and P. Hirszel. 2000. Gliotoxin-induced cytotoxicity proceeds via apoptosis and is mediated by caspases and reactive oxygen species in LLC-PK1 cells. Toxicol Sci. 54:194-202.[Abstract/Free Full Text] |
| 21. | Zychlinsky, A., B. Kenny, R. Menard, M. C. Prevost, I. B. Holland, and P. J. Sansonetti. 1994. ipaB mediates macrophage apoptosis induced by Shigella flexneri. Mol. Microbiol. 11:619-627.[Medline] |
| 22. | Zychlinsky, A., and P. J. Sansonetti. 1997. Apoptosis as a proinflammatory event: what can we learn from bacteria-induced cell death? Trends Microbiol. 5:201-204.[CrossRef][Medline] |